Cargando…

Association of Systolic Blood Pressure with Progression of Symptomatic Intracranial Atherosclerotic Stenosis

BACKGROUND AND PURPOSE: Elevated blood pressure (BP) is associated with greater severity of intracranial atherosclerotic stenosis (ICAS) and increased risk of ischemic stroke. Because little is known about the relationship of maintained BP level with progression of symptomatic ICAS (sICAS), we evalu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jong-Ho, Ovbiagele, Bruce, Hong, Keun-Sik, Kwon, Sun U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Stroke Society 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647639/ https://www.ncbi.nlm.nih.gov/pubmed/29037004 http://dx.doi.org/10.5853/jos.2017.00136

Ejemplares similares

Platelet-Derived Growth Factor Is Associated with Progression of Symptomatic Intracranial Atherosclerotic Stenosis
por: Kim, Kyeong Joon, et al.
Publicado: (2021)

Is the future of symptomatic intracranial atherosclerotic stenosis management promising?
por: Liu, Dacheng, et al.
Publicado: (2020)

A Need for Tailored Approach for Patients with Symptomatic Intracranial Atherosclerotic Stenosis
por: Kate, Mahesh P., et al.
Publicado: (2020)

Enterprise stent for symptomatic complex intracranial atherosclerotic stenosis: safety and efficiency
por: Dong, Yanhua, et al.
Publicado: (2019)

Radiomics Nomogram for Predicting Stroke Recurrence in Symptomatic Intracranial Atherosclerotic Stenosis
por: Tang, Min, et al.
Publicado: (2022)

Predictors of hyperperfusion syndrome after stent implantation in symptomatic intracranial atherosclerotic stenosis
por: Yan, Long, et al.
Publicado: (2022)

Functional evaluation of intracranial atherosclerotic stenosis by pressure ratio measurements
por: Wang, Ming, et al.
Publicado: (2023)

Enterprise stent for the treatment of symptomatic intracranial atherosclerotic stenosis: an initial experience of 44 patients
por: Feng, Zhengzhe, et al.
Publicado: (2015)

Plaque Characteristics in Young Adults With Symptomatic Intracranial Atherosclerotic Stenosis: A Preliminary Study
por: Li, Ling, et al.
Publicado: (2022)

Intracranial Spotty Calcium Predicts Recurrent Stroke in Patients with Symptomatic Intracranial Atherosclerotic Stenosis: A Prospective Cohort Study
por: Li, Rui, et al.
Publicado: (2023)

Blood biomarkers of progressive atherosclerosis and restenosis after stenting of symptomatic intracranial artery stenosis
por: Haidegger, Melanie, et al.
Publicado: (2021)

Primary Angioplasty for Symptomatic Atherosclerotic Middle Cerebral Artery Stenosis
por: Chang, Youn Hyuk, et al.
Publicado: (2014)

Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Disease
por: Short, Jody L., et al.
Publicado: (2011)

Outcome of Endovascular Treatment in Symptomatic Intracranial Vascular Stenosis
por: Suh, Dae Chul, et al.
Publicado: (2005)

Intervals of endovascular treatment for coincidental non-adjacent unruptured aneurysms in patients with symptomatic intracranial atherosclerotic stenosis
por: Jin, Hengwei, et al.
Publicado: (2022)

Stroke recurrence is associated with unfavorable intracranial venous outflow in patients with symptomatic intracranial atherosclerotic large vessel severe stenosis or occlusion
por: Gao, Jiali, et al.
Publicado: (2023)

Plaque morphology in acute symptomatic intracranial atherosclerotic disease
por: Leung, Thomas W, et al.
Publicado: (2021)

Wingspan Stenting for Severe Symptomatic Intracranial Atherosclerotic Stenosis in 433 Patients Treated at a Single Medical Center
por: Li, Tian-Xiao, et al.
Publicado: (2015)

Qualitative and quantitative plaque enhancement on high‐resolution vessel wall imaging predicts symptomatic intracranial atherosclerotic stenosis
por: Huang, Li‐Xin, et al.
Publicado: (2023)

Identifying risk factors for in-stent restenosis in symptomatic intracranial atherosclerotic stenosis: a systematic review and meta-analysis
por: Wang, Ning, et al.
Publicado: (2023)

Elevated homocysteine as an independent risk for intracranial atherosclerotic stenosis
por: Liu, Ying, et al.
Publicado: (2019)

Importance of lipid ratios for predicting intracranial atherosclerotic stenosis
por: Yang, Wen-Song, et al.
Publicado: (2020)

Association of peripheral neutrophil count with intracranial atherosclerotic stenosis
por: Zhang, Xing, et al.
Publicado: (2020)

Prevalence, prognosis, and treatment of atherosclerotic intracranial stenosis in Caucasians
por: Hurford, Robert, et al.
Publicado: (2020)

Intra-Arterial Glycoprotein IIb/IIIa Inhibitor Treatment for Symptomatic Intracranial Atherosclerotic Stenosis Presenting as Large Vessel Occlusions
por: Srivatsan, Aditya, et al.
Publicado: (2020)

Serum Bilirubin Levels and Extent of Symptomatic Intracranial Atherosclerotic Stenosis in Acute Ischemic Stroke: A Cross-Sectional Study
por: Yu, Fang, et al.
Publicado: (2021)

Complications and long-term in-stent restenosis of endovascular treatment of severe symptomatic intracranial atherosclerotic stenosis and relevant risk factors
por: Yang, Lei, et al.
Publicado: (2023)

Determinants of visit-to-visit systolic blood pressure variability among Ghanaians with hypertension and diabetes mellitus
por: Sarfo, Fred S, et al.
Publicado: (2023)

Associations of neutrophil-to-lymphocyte ratio with intracranial and extracranial atherosclerotic stenosis
por: Xie, Yu, et al.
Publicado: (2022)

A retrospective study of individualized endovascular treatment for symptomatic intracranial atherosclerotic stenosis in patients with ischemic stroke/transient ischemic attack
por: Mao, Lun-Lin, et al.
Publicado: (2022)

A Study Design to Evaluate Association between Smoking and Intracranial Atherosclerotic Stenosis
por: Liu, Hairi, et al.
Publicado: (2014)

End-systolic wall stress in aortic stenosis: comparing symptomatic and asymptomatic patients
por: Carter-Storch, Rasmus, et al.
Publicado: (2019)

Safety of Low-Dose Aspirin in Endovascular Treatment for Intracranial Atherosclerotic Stenosis
por: Ma, Ning, et al.
Publicado: (2014)

Treatment and imaging of intracranial atherosclerotic stenosis: current perspectives and future directions
por: van den Wijngaard, Ido R., et al.
Publicado: (2016)

Endovascular Treatment of Intracranial Atherosclerotic Stenosis: Current Debates and Future Prospects
por: Luo, Jichang, et al.
Publicado: (2018)

The lymphocyte-to-monocyte ratio predicts intracranial atherosclerotic stenosis plaque instability
por: Wu, Xiao-Bing, et al.
Publicado: (2022)

Low Common Carotid Artery Systolic Occlusion Pressure and Symptomatic Carotid Artery Stenosis Are Associated with Development of Neurologic Intolerance during Proximal Protected Carotid Artery Stenting
por: Kwon, Hee-Jin, et al.
Publicado: (2017)

Long-term Outcomes of Drug-eluting Stents in Symptomatic Intracranial Stenosis
por: Park, Soonchan, et al.
Publicado: (2013)

Effects of cilostazol on the progression and regression of symptomatic intracranial artery stenosis: it reduces the risk of ischemic stroke
por: Zhang, Wen-hui, et al.
Publicado: (2015)

Multimarker Approach in Discriminating Patients with Symptomatic and Asymptomatic Atherosclerotic Carotid Artery Stenosis
por: Musialek, Piotr, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4vs4dcth9ltofhq5sgbcro9f8t